ArticleBMC health services research2024

An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a German healthcare payer perspective.

Malte Kuniss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.